Education
About Us
Working with TipRanks
Follow Us
Clover Health Investments (DE:7QD)
FRANKFURT:7QD
RESEARCH TOOLSreports
7QD Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.59 - €4.55
Previous CloseN/A
Volume0.00
Average Volume (3M)76.00
Market Cap
$1.52B
Enterprise Value€1.55B
Total Cash (Recent Filing)$67.60M
Total Debt (Recent Filing)$57.92M
Price to Earnings (P/E)―
Beta1.31
Next Earnings
May 06, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding418,531,700
10 Day Avg. Volume2
30 Day Avg. Volume76
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.39
Price to Cash Flow (P/CF)-5.50
P/FCF Ratio0.00
Enterprise Value/Market Cap1.02
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.25
Enterprise Value/Ebitda-35.12
Forecast
1Y Price Target
$3.80Price Target Upside34.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
---
Clover Health Investments News
PremiumCompany Announcements
Clover Health Announces Board Leadership Change
PremiumCompany Announcements
Clover Health’s Earnings Call Highlights Profitability and Growth---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceClover has reimmersed itself into growth, with strong AEP performance and continued investments yielding management's bullish commentary on membership and Stars performance.
Market PositionClover's success in attaining a 4.0 Stars rating for its PPO plan has proven successful in helping the company take market share in its core markets.
Technology And InnovationClover Health is a disrupter in the physician enablement and Medicare Advantage markets and their Clover Assistant (CA), which utilizes AI and ML, is changing the way patients are treated which in turn is reducing cost of care and ultimately leading to greater cash flow and earnings to CLOV shareholders.
Bears Say
Expense IncreaseBER is expected to be 87-88% in 2025 vs. 81.2% in 2024, indicating increased expenses.
Guidance ConcernsShares are down after the 3Q report, likely as the updated guidance implies 4Q adj-EBITDA may swing negative.
Revenue ShortfallReported revenues of $337m missed consensus and our estimate by 2.9% and 2.0%, respectively.
---
Options Prices
Currently, No data available
---
Ownership Overview
6.75% Insiders
5.65%
Mutual Funds
1.29% Other Institutional Investors
79.83% Public Companies and
Individual Investors
7QD FAQ
What was Clover Health Investments’s price range in the past 12 months?
Clover Health Investments lowest stock price was €0.58 and its highest was €4.55 in the past 12 months.
What is Clover Health Investments’s market cap?
Clover Health Investments’s market cap is $1.52B.
When is Clover Health Investments’s upcoming earnings report date?
Clover Health Investments’s upcoming earnings report date is May 06, 2025 which is in 12 days.
How were Clover Health Investments’s earnings last quarter?
Clover Health Investments released its earnings results on Feb 27, 2025. The company reported -€0.035 earnings per share for the quarter, beating the consensus estimate of -€0.058 by €0.023.
Is Clover Health Investments overvalued?
According to Wall Street analysts Clover Health Investments’s price is currently Undervalued.
Does Clover Health Investments pay dividends?
Clover Health Investments does not currently pay dividends.
What is Clover Health Investments’s EPS estimate?
Clover Health Investments’s EPS estimate is -0.04.
How many shares outstanding does Clover Health Investments have?
Clover Health Investments has 418,531,700 shares outstanding.
What happened to Clover Health Investments’s price movement after its last earnings report?
Clover Health Investments reported an EPS of -€0.035 in its last earnings report, beating expectations of -€0.058. Following the earnings report the stock price went down -8.909%.
Which hedge fund is a major shareholder of Clover Health Investments?
Currently, no hedge funds are holding shares in DE:7QD
---
Clover Health Investments Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.80 (34.12% Upside)
$3.80 (34.12% Upside)
Blogger Sentiment
Bullish
DE:7QD Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
450.07%
12-Months-Change
Fundamentals
Return on Equity
-14.75%
Trailing 12-Months
Asset Growth
1.76%
Trailing 12-Months
Company Description
Clover Health Investments
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
---
7QD Company Deck
---
7QD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted several strong achievements, such as achieving profitability, significant membership growth, and improved star ratings. However, there were concerns regarding increased SG&A expenses and the impact of minimum MLR rebates on revenue. Overall, the positive aspects outweighed the challenges.Read More>---
7QD Stock 12 Month Forecast
Average Price Target
€3.80
▲(34.12% Upside)
Technical Analysis
Best Analysts Covering 7QD
1 Year
1 Year Success Rate
7/15 ratings generated profit
1 Year Average Return
+86.43%
reiterated a buy rating 18 days ago
Copying Richard Close's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of +86.43% per trade.
---